Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.56 USD
Change Today -0.205 / -3.56%
Volume 177.4K
PACB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 12:56 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Susan K. Barnes

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Pacific Biosciences of California, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 7 different industries.

See Board Relationships
61$1,169,401
As of Fiscal Year 2014

Background*

Ms. Susan K. Barnes has been the Chief Financial Officer of Pacific Biosciences of California, Inc. since February 2010, Executive Vice President since December 2010 and as its Principal Accounting Officer since April 2015. Ms. Barnes served as Senior Vice President of Pacific Biosciences of California, Inc. from February 2010 to December 2010. Ms. Barnes has nearly 30 years experience in senior financial management. She served as the Chief Financial Officer, Senior ...

Read Full Background

Corporate Headquarters*

1380 Willow Road
Menlo Park, California 94025

United States

Phone: 650-521-8000
Fax: --

Board Members Memberships*

Former Director
2004-2006
Former Director and Chairman of Audit Committee
2006-Present
Director and Chairman of Audit Committee

Education*

BA
Bryn Mawr College
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$1
Total Annual Compensation$1

Stock Options*

Exercisable Options740,853
Exercisable Options Value$1,180,811
Unexercisable Options587,089
Unexercisable Options Value$1,901,939
Total Value of Options$3,082,750
Total Number of Options1,327,942

Total Compensation*

Total Annual Cash Compensation$1
Total Short Term Compensation$1
Total Calculated Compensation$1,169,401
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PACB:US $5.56 USD -0.205

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$433.0K
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Gajus V. Worthington Co-Founder, Chief Executive Officer, President and Director
Fluidigm Corporation
$490.0K
Rolland D. Carlson Ph.D.Chief Executive Officer and President
WaferGen Bio-systems, Inc.
--
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIFIC BIOSCIENCES OF CALIF, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.